[Tc-99m]-Medronate (2017-09-22)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: Hospitals, Healthcare Professionals, General Public
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| M-170830MDP-1, M-170830MDP-2, | [Tc-99m]-Medronate | - Recalling Firm
- Centre for Probe Development and Commercialization (CPDC)
- 1280 Main St. W. NRB-A316
- Hamilton
- L8S 4K1
- Ontario
- CANADA
- Marketing Authorization Holder
- Not Applicable
| Liquid | No market authorization | 14.30, 3.39, and 4.87 GBq |
Affected products
[Tc-99m]-Medronate
The sterility may be out of specification in the affected lots.
3 Hospitals located in Hamilton, Ontario, Canada